Posted on Leave a comment

Halted Progression of Soft Palate Cancer in a Patient Treated with the Paleolithic Ketogenic Diet Alone: A 20-months Follow-up

URL: http://pubs.sciepub.com/ajmcr/4/8/8/

American Journal of Medical Case Reports

Publication Date: 08/2016

Summary: Here we present a case with myoepithelial tumor of the soft palate where the patient denied conventional treatment options. Instead, the patient started the paleolithic ketogenic diet which resulted in a halted progression of the tumor as evidenced by imaging follow-up. Currently, the patient is on the diet for 20 months, without symptoms and side effects.

Posted on

Paleolithic ketogenic diet (PKD) in chronic diseases: Clinical and research data

URL: https://jevohealth.com/cgi/viewcontent.cgi?article=1115&context=journal

Journal of Evolution and Health

Publication Date: 03/2019

Summary: In the presentation we give an overview of our clinical experience and research with the paleolithic ketogenic diet (PKD), a diet that was developed by the ICMNI team. Since 2012 we have been exclusively using this approach in the treatment of a wide array of chronic conditions. We use the combined term u201dpaleolithic ketogenicu201d because the diet has its roots in both, the paleolithic and the ketogenic diet. The PKD combines the benefits of the two diets while excluding shortcomings of both diets. We have to emphasise the fact that both the classic version of the ketogenic diet and the popular version of the paleolithic diet are associated with side-effects. The side-effects of the classic ketogenic diet have been well- documented through its use over the last hundred years, whereas, the shortcomings of the popular paleolithic diet are less well-known. As examples for the side-effects, we present a patient who, after 7 years on the popular paleolithic diet, developed severe atherosclerosis, and another patient who, after following the classic ketogenic diet for 17 years, developed tophi (deposition of urate crystals in soft tissues) in multiple locations on hands and feet. Since 2012 we have been using the PKD on more than 4000 patients including those with autoimmune diseases, cancer, psychiatric and neurologic conditions. In the presentation we focus on presenting data on type 1 diabetes (T1DM) and cancer patients, as well as showing research data related to intestinal permeability measurements in healthy persons as well as in patients.

Posted on

Ketogenic diet rescues cognition in ApoE4+ patient with mild Alzheimer’s disease: A case study

URL: https://www.sciencedirect.com/science/article/abs/pii/S1871402118306684?via%3Dihub

Journal: Diabetes & Metabolic Syndrome: Clinical Research & Reviews

 Publication Date: 03/2019

Summary: The significant results in both MetS biomarkers and the MoCA score suggest that a ketogenic diet may serve to rescue cognition in patients with mild AD. The results of this case study are particularly compelling for ApoE4 positive (ApoE4+) subjects as ketogenic protocols extend hope and promise for AD prevention.

Posted on

Successful Treatment of Type 1 Diabetes and Seizures With Combined Ketogenic Diet and Insulin

URL: https://pediatrics.aappublications.org/content/129/2/e511

Journal: Pediatrics

 Publication Date: 02/2012

Summary: Case report of a 2 year old that presented with diabetic ketoacidosis and a history of epilepsy. She was treated with a ketogenic diet, insulin and fluids. During a 10 month follow up she had no additional seizures or episodes of diabetic ketoacidosis.